Autonomic disorders in patients with peripheral neuropathies. 1986

Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi

UI MeSH Term Description Entries
D007464 Clioquinol A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide. Chloroiodoquine,Iodochlorhydroxyquin,Iodochloroxyquinoline,5-Chloro-7-iodo-8-quinolinol,Chinoform,Entero-Septol,Entero-Vioform,Enteroquinol,Vioform,5 Chloro 7 iodo 8 quinolinol,Entero Septol,Entero Vioform,EnteroSeptol,EnteroVioform
D009412 Nerve Fibers Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM. Cerebellar Mossy Fibers,Mossy Fibers, Cerebellar,Cerebellar Mossy Fiber,Mossy Fiber, Cerebellar,Nerve Fiber
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D002422 Causalgia A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359) Complex Regional Pain Syndrome Type II,CRPS Type II,Causalgia Syndrome,Deafferentation Pain,Type II Complex Regional Pain Syndrome,Causalgia Syndromes,Pain, Deafferentation,Syndrome, Causalgia,Syndromes, Causalgia
D005260 Female Females
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D000795 Fabry Disease An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders. Anderson-Fabry Disease,Angiokeratoma Corporis Diffusum,Angiokeratoma Diffuse,Angiokeratoma, Diffuse,Ceramide Trihexosidase Deficiency,Fabry's Disease,GLA Deficiency,Hereditary Dystopic Lipidosis,alpha-Galactosidase A Deficiency,alpha-Galactosidase A Deficiency Disease,Anderson Fabry Disease,Deficiency, Ceramide Trihexosidase,Deficiency, GLA,Deficiency, alpha-Galactosidase A,Diffuse Angiokeratoma,Lipidosis, Hereditary Dystopic,alpha Galactosidase A Deficiency,alpha Galactosidase A Deficiency Disease

Related Publications

Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
January 1984, Duodecim; laaketieteellinen aikakauskirja,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
June 1996, Journal of the neurological sciences,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
December 1996, Revista de neurologia,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
February 2017, Pediatric clinics of North America,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
October 2021, Current opinion in neurology,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
February 2023, Muscle & nerve,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
October 2021, Current opinion in neurology,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
March 2001, Journal of clinical neuromuscular disease,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
July 1966, Das Deutsche Gesundheitswesen,
Y Kuroiwa, and I Goto, and Y Itoyama, and S Tobimatsu, and J Ochiai, and H Furuya, and T Yamada, and J Tateishi, and A Ohnishi
December 2009, Revue neurologique,
Copied contents to your clipboard!